heat News and Research

RSS

Debiopharm commences treatment in Phase I clinical trial for Debio 0932 small molecule Hsp90 inhibitor

Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the first patient in a Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305.

27 Apr 2010

ThermaCor 1200 Rapid Thermal Infusion System used successfully in multiple clinical cases

Smisson-Cartledge Biomedical LLC, an innovator in life saving cardiovascular devices, announced today that its ThermaCor 1200 Rapid Thermal Infusion System has been used successfully in multiple clinical cases in the United States and in the Kingdom of Saudi Arabia.

26 Apr 2010

Mimicking human nervous system for bionic applications can become a reality: Researchers

Mimicking the human nervous system for bionic applications could become a reality with the help of a method developed at Oak Ridge National Laboratory to process carbon nanotubes.

26 Apr 2010

Temperature-sensing ability in proteins remain a mystery

Scientists at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF) have shed new light on the molecular mechanism that enables us to sense temperature, such as the heat from a sizzling stove. In addition to contributing to our knowledge of basic biology, the findings could one day lead to new therapies for conditions such as acute or chronic inflammatory pain.

24 Apr 2010

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.

23 Apr 2010

Report highlights 11 key categories of diseases, health consequences that occur due to climate change

A report released today by a federal working group highlights 11 key categories of diseases and other health consequences that are occurring or will occur due to climate change. The report, A Human Health Perspective on Climate Change, provides a starting point for coordination of federal research to better understand climate's impact on human health.

22 Apr 2010

Researchers demonstrate role of HSP-90 in portal hypertension

Neural vasoregulation represents a rapid and potent mode of altering vascular tone but has not been investigated thoroughly during portal hypertension. Heat shock protein-90 is well-known to act as a molecular chaperone optimizing endothelial and neural NO-synthase enzyme activity and thus, NO production.

21 Apr 2010

Early diagnosis of varicose vein disease leads to simpler treatments and better outcomes

Varicose vein disease is an underappreciated and often misunderstood medical condition, causing many individuals to be misdiagnosed, mistreated - or ignored - resulting in needless suffering and complications from progressively worsening symptoms. Unfortunately, patients typically wait until the disease reaches a more difficult to treat and debilitating stage: they have lifestyle limiting pain, unsightly bulging veins and spider veins, leg swelling or skin ulceration.

21 Apr 2010

FDA files consent decree against STERIS

The U.S. Food and Drug Administration today announced that a consent decree has been filed against the device manufacturer, STERIS Corp. of Mentor, Ohio. The decree stops the company from distributing unapproved and misbranded devices used to sterilize heat-sensitive instruments and medical devices. It prohibits the distribution of the STERIS System 1 Processor, or SS1, a tabletop liquid chemical system marketed to disinfect certain devices, such as endoscopes, that cannot withstand steam sterilization.

21 Apr 2010

Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

Celsion Corporation today announced that Dr. Thanjavur S. Ravikumar, from the Geisinger Health System and a principal investigator of the Phase I ThermoDox® dose escalation trial, gave an oral presentation at the Liver Tumors Panel session of the 9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA) in Buenos Aires, Argentina.

21 Apr 2010

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.

20 Apr 2010

Clinical success of LOW LEVEL LASER THERAPY to treat FMS reported in Fibromyalgia Aware

Fibromyalgia is a condition in which the brain processes pain in an abnormal way, resulting in chronic, widespread muscular-skeletal pain and chronic fatigue. This condition effects millions of Americans and has been poorly understood and under diagnosed, resulting in billions of dollars in cost to our health care system.

20 Apr 2010

Solid-state illuminator used in greenhouses decreases nitrates, increases nutrient levels

Searching for ways to improve the nutritional quality of leafy green vegetables, Lithuanian researchers have found success with new technology that features high-density photosynthetic photon flux generated by a solid-state illuminator.

19 Apr 2010

Structure of Amyloid fibers surprises researchers

The Atomic Force Microscope depicts on its screen the few nanometer thick and few micrometer long fibers as white flexible sticks, crisscrossing the surface on which they are deposited. The very peculiar property of these proteins lies in fact that they can self assemble into complex ribbon-like twisted fibers.

19 Apr 2010

Project to integrate data from climate modelling, disease forecasting systems for predicting epidemics

Researchers across 13 European and African research institutes will work together to integrate data from climate modelling and disease forecasting systems to predict the likelihood of an epidemic up to six months in advance. The research, funded by the European Commission Seventh Framework programme, will focus on climate and disease in Senegal, Ghana and Malawi and aims to give decision makers the necessary time to deploy intervention methods to help prevent large scale spread of diseases such as Rift Valley Fever and malaria.

17 Apr 2010

Exergen's TemporalScanner effective alternative to rectal thermometry

According to a recent study published by the Journal of Pediatric Nursing, "The utilization of temporal artery thermometry offers a reliable method to measure temperature while also offering significant comfort benefits to children, decreasing risks associated with the rectal thermometry method, improving the quality and efficiency of nursing care, and improving patient and family satisfaction."

16 Apr 2010

Escherichia coli cases drop in 2009

As per a report from the Centers for Disease Control and Prevention (CDC) a 12 % drop in rates of Escherichia coli (E.coli) infection has been noted in 2009 as compared to statistics for 2008. This is being seen by federal health officials as a sign that the new food safety measures are effective. Most of the pathogens under study are from the bacteria family like E.coli 0157, salmonella, campylobacter, listeria and vibrio. It was found that food poisoning rates for the most common pathogens have changed little from statistics collected in 2004.

16 Apr 2010

Trans-urethral prostate hyperthermia treatment offers 100% response rate

According the Dr. Friedrich Douwes, Medical Director of St. George Hospital in Bad Aibling, Germany, president of the German Oncological Society and the author of several hundred scientific articles and books, trans-urethral prostate hyperthermia has a 100% initial response rate.

16 Apr 2010

Exclusive licensing practices slows innovation in gene testing market

Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk, say researchers at the Duke Institute for Genome Sciences & Policy (IGSP).

15 Apr 2010

Rush University Medical Center's Orthopedic Building awarded Gold LEED certification

The U.S. Green Building Council has awarded the Orthopedic Building at Rush University Medical Center Gold Leadership in Energy and Environmental Design (LEED) certification. LEED is an internationally recognized green building certification system and the nationally accepted benchmark for the design, construction and operation of high performance green buildings.

15 Apr 2010

heat News and Research

Debiopharm commences treatment in Phase I clinical trial for Debio 0932 small molecule Hsp90 inhibitor

ThermaCor 1200 Rapid Thermal Infusion System used successfully in multiple clinical cases

Mimicking human nervous system for bionic applications can become a reality: Researchers

Temperature-sensing ability in proteins remain a mystery

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

Report highlights 11 key categories of diseases, health consequences that occur due to climate change

Researchers demonstrate role of HSP-90 in portal hypertension

Early diagnosis of varicose vein disease leads to simpler treatments and better outcomes

FDA files consent decree against STERIS

Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

Clinical success of LOW LEVEL LASER THERAPY to treat FMS reported in Fibromyalgia Aware

Solid-state illuminator used in greenhouses decreases nitrates, increases nutrient levels

Structure of Amyloid fibers surprises researchers

Project to integrate data from climate modelling, disease forecasting systems for predicting epidemics

Exergen's TemporalScanner effective alternative to rectal thermometry

Escherichia coli cases drop in 2009

Trans-urethral prostate hyperthermia treatment offers 100% response rate

Exclusive licensing practices slows innovation in gene testing market

Rush University Medical Center's Orthopedic Building awarded Gold LEED certification

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News